GenapSys, Inc. is committed to a new era of applied genomic testing and a new paradigm for medical sequencing. We are developing a cost-disruptive, easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology which delivers 100x improvement in cost and speed. These innovations will enable a new era of medicine through the widespread acquisition of genomic data for research and testing of genetic disease, cancer, and microbes.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
EQUITYZEN and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.